Key Points

India's medical technology sector is on a rapid growth trajectory, expected to reach $50 billion by 2030 from its current $12 billion valuation. Dr Jitendra Singh highlighted the crucial role of institutions like SCTIMST in developing affordable, high-quality medical devices. The minister emphasized the need to scale up production and increase public awareness of these indigenous innovations. These developments align with India's vision of becoming a global hub for cost-effective healthcare and medical tourism by 2047.

Key Points: India MedTech Sector to Hit $50 Billion by 2030 Says Dr Jitendra Singh

  • MedTech sector currently valued at $12B growing at 20% annually
  • SCTIMST has provided heart valves to over two lakh patients
  • Institute's innovations include Hemostasis Patch for trauma care
  • Unique "Four Ts" model combines Teaching, Training, Treatment and Trade
2 min read

India's MedTech sector projected to touch $50 billion by 2030: Dr Jitendra Singh

Union Minister Dr Jitendra Singh projects India's MedTech sector will grow from $12B to $50B by 2030, highlighting SCTIMST's role in affordable medical devices.

"India holds the promise of emerging as a global destination for cost-effective quality healthcare - Dr Jitendra Singh"

New Delhi, Oct 3

India’s medical technology sector is valued at around $12 billion in 2025 and is growing at nearly 20 per cent annually, with projections to touch $50 billion by 2030, Dr Jitendra Singh, Minister of State (Independent Charge) for Science and Technology, and Earth Sciences, said on Friday.

India holds the promise of emerging as a global destination for cost-effective quality healthcare, the minister said while inaugurating a medical exhibition at Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thiruvananthapuram.

The minister hailed the institution for producing high-quality medical devices at affordable prices and called for scaling up production and expanding awareness of these indigenous innovations.

He highlighted that SCTIMST’s contributions align with the Prime Minister’s vision of Atmanirbhar Bharat by reducing reliance on imports, Vishwabandhu Bharat by exporting devices like heart valves and MRI-compatible shunts and Viksit Bharat 2047 through revenue generation and industry partnerships in the private sector.

Citing examples, Dr Singh said the institute has already provided heart valves to over two lakh patients and advanced shunts to about 2,000 patients, while innovations like the Hemostasis Patch have proved critical in trauma and battlefield care.

He noted that such achievements are often under-recognised even within leading hospitals and called for scaling up production to make them more widely available.

Singh said that while SCTIMST has developed life-saving technologies, more needs to be done to ensure wider use and public awareness.

He suggested that the institute showcase its devices in central locations such as Delhi, involving civil society and stakeholders, so that the benefits of its work are better known.

The minister further stressed that SCTIMST represents a unique model in India by combining the “Four Ts” — Teaching, Training, Treatment and Trade — a concept common in some Western countries but relatively new domestically.

The institute, he said, not only educates and treats but also generates economic value through manufacturing.

He added that the institute can contribute to India’s emergence as a global hub for cost-effective healthcare and medical tourism by 2047.

- IANS

Share this article:

Reader Comments

R
Rohit P
Heart valves for 2 lakh patients - that's incredible! But why aren't these achievements getting more publicity? As Dr Singh said, we need better awareness about our own innovations. Most people still think foreign medical devices are superior.
A
Arjun K
The "Four Ts" model is brilliant! Teaching, Training, Treatment and Trade - this holistic approach can revolutionize healthcare education and delivery. Hope other institutions adopt this model across India.
M
Michael C
As someone working in healthcare, I've seen how expensive imported medical devices are. If India can produce quality alternatives at lower costs, it will benefit patients worldwide. The Hemostasis Patch for trauma care sounds particularly promising.
S
Shreya B
While the projections are exciting, I hope the government ensures these indigenous devices reach rural areas too. Often such innovations remain confined to major cities. Healthcare equality should be the priority. 🙏
K
Karthik V
Atmanirbhar Bharat in action! Reducing import dependency in medical devices is crucial for national security and economic growth. The export potential mentioned shows we can compete globally. Proud moment for Indian healthcare! 💪
E
Emma D
The medical tourism angle is smart thinking. If India can offer world-class treatment with cost-effective indigenous devices, it could become a major destination for

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50